CDSCO issues FAQ for implementation Barcode requirement on the label of 300 brands of drugs

CDSCO issues FAQ for implementation Barcode requirement on the label of 300 brands of drugs

CDSCO issues FAQ for implementation Barcode requirement on the label of 300 brands of drugs

by Lexplosion | Aug 1, 2023 | Central, OPS, Pharmaceuticals

Central Drugs Standard Control Organization has issued a FAQ for implementation of the requirement... Read More

NPPA extends date for filing quarterly returns for quarter ended September, 2022 and MRP revisions of scheduled and non-scheduled drugs and medical devices till 31st December, 2022

NPPA extends date for filing quarterly returns for quarter ended September, 2022 and MRP revisions of scheduled and non-scheduled drugs and medical devices till 31st December, 2022

by Lexplosion | Nov 2, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

CDSCO issues a list of spurious, adulterated, misbranded, or non-standard quality drugs, medical devices and cosmetics for the month of September, 2022

CDSCO issues a list of spurious, adulterated, misbranded, or non-standard quality drugs, medical devices and cosmetics for the month of September, 2022

by Lexplosion | Oct 21, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Ministry of Health releases revised National List of Essential Medicines; 34 new drugs added to list and 26 drugs deleted

Ministry of Health releases revised National List of Essential Medicines; 34 new drugs added to list and 26 drugs deleted

by Lexplosion Solution | Sep 19, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

National Pharmaceutical Pricing Authority fixes the retail price for certain formulations; overcharged amount (with interest) to be imposed for non-compliance

National Pharmaceutical Pricing Authority fixes the retail price for certain formulations; overcharged amount (with interest) to be imposed for non-compliance

by Lexplosion Solution | Apr 21, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

« Older Entries

Next Entries »